Find Clinical Trials | Cedars-Sinai

119 results found

Gastrointestinal Cancer, Liver Cancer

Microbial Biomarkers for Hepatocellular Carcinoma

This study focuses on patients who are about to begin treatment for advanced liver cancer at Cedars-Sinai. The purpose of the study is to determine how bacteria in the digestive tract could contribute to response ...

Melanoma, Other Skin, Other Urinary, Ovary, Unknown Sites

IMC-F106C in Advanced Cancers

The purpose of this study is to determine the safety and effectiveness of an investigational immunotherapeutic drug called IMC-F106C in multiple cancers (endometrial, ovarian, melanoma, ocular melanoma, triple-negative breast, lung, and bladder cancer) expressing a ...

Leukemia, not otherwise specified

Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL

This study focuses on individuals who have been diagnosed with mixed-phenotype acute leukemia (MPAL). MPAL is a cancer of the white blood cells that occurs in the bone marrow and is a rare form of ...

Melanoma, Soft Tissue

Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Melanoma

Substudies 02A, 02B, and 02C: To assess the safety and tolerability of investigational treatment combinations based on the proportion of participants with adverse events (AEs). Substudies 02A and 02B: To evaluate objective response rate (ORR) as assessed ...

Prostate

Mechanisms of Glutamine Metabolism in Prostate Cancer Progression

This study focuses on patients with a specific stage of prostate cancer known as metastatic, castration-sensitive or metastatic, castration-resistant prostate cancer who are still receiving androgen targeting therapy (a type of prostate cancer therapy). The ...